Highlights the rare but aggressive risk of secondary angiosarcoma following postoperative radiotherapy for breast cancer, requiring a high index of clinical suspicion.
Warrants heightened suspicion for secondary angiosarcoma after breast radiotherapy; extends sparse case-based evidence on this rare entity.
Angiosarcomas are rare and aggressive malignant tumours of vascular or endothelial origin that can originate in the breast. They can be classified as primary or secondary, with the latter most commonly due to postoperative radiotherapy as part of breast conservation therapy (wide local excision and adjuvant radiotherapy) for breast cancer. We report a case of postirradiation secondary angiosarcoma in a 56-year-old woman, alongside a review of the current literature, to inform clinicians of its clinical presentation and characteristics as a high index of clinical suspicion is required for an accurate diagnosis.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: